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In order to evaluate the esterasic activity within the viable embryos we used the 
Fluorescein diacetate (FDA) staining test. For staining was used a 0.5 mg/ml FDA 
stock solution. The embryos were recovered at 48 hours post coitus from 
superovulated Swiss mouse females. Before staining the embryos were 
microscopically evaluated by morphological criteria and classified in 4 quality 
codes. The two methods used for quality and viability assessment were correlated 
applying Pearson coefficient. The calculated value of the Pearson coefficient (r=1) 
showed a strong correlation between the two methods used and indicate FDA 
staining test and esterasic activity as a fast, easy and reliable method for embryo 
viability assessment. 
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Introduction 
 
The fluorescence staining allows high precision detection of the specific 
components within the living cells. Fluoresceine diacetate (FDA) is a 
nonfluorescent analog of fluoresceine which can easily penetrate the cellular 
membrane of the living cells and under cellular esterase activity is hydrolyzed to 
fluoresceine. The FDA metabolism depends on the esterasic activity and at the 
same time on the plasmatic membrane integrity. The Fluoresceine diacetate can be 
used together with other dye, Propidium iodide (Pi), which poses the capacity to 
penetrated the cellular membrane of the nonviable cells, binds inside the DNA 
molecules and show a red fluorescence while the cells are exposed to a 
fluorescence microscope. The use of the two dyes increases the accuracy of viable 
and nonviable cells identification (Kroesen, 1992).  
The embryo viability assessment is an important step for the embryo transfer 
procedure. The morphological criteria evaluation is, at the moment, the most used 
method for embryo quality assessment, but the results and objectivity of the 
method are very much influenced by the operator experience. Fluorescence 
staining allows viable cells identification by enzymatic activity detection within the 
cells. The aim of the paper was to assess the mouse embryo viability by esterasic   2
activity using fluorescence staining methods (FDA staining test). 
 
Materials and Methods 
 
As biological material we used 27 days old, Swiss mice females, hormonal 
stimulated. The superovulation treatment was made administrating 5 UI/ml PMSG 
injection, followed at 48 hours by an other 5 UI/ml hCG injection. The embryo 
recovery was made 48 hours post coitus. The embryo manipulation was made in 
M2 media (cat. no. M7167). Following embryo recovery the embryos were 
tested for esterasic activity detection using FDA staining.  
For staining with fluorochrome we used a 0.5 mg/ml FDA stock solution, 
diluted before staining by adding 50 μl FDA stock solution in 1 ml M2 media. For 
esterasic activity detection the embryos were introduce in the staining solution and 
incubated for 5 minutes, at 37°, 5% CO2 and than visualized at 490-518 nm using a 
fluorescence microscope. The viable embryos manifesting esterasic activity within 
the blastomers showed a green fluorescence. 
 
Results and Discussion 
 
For this experiment we used 37 embryos. The developmental stages of the 
recovered embryos are presented in table 1. 
Table 1 
Developmental stages of the recovered embryos 
Recovered 
embryos 
2 cells  8 cells  Morula  Blastocyst 
n  n % n % N %  n  % 
37 3  8.10  16  43.24  10  27.02  8  21.62 
 
From the 37 recovered embryos, 8.10% were in 2 cells stage, 43.24% were in 
8 cell stage, 27.02% were in morula stage and 21,62% were in blastocyst stage. 
The embryos recovered were first microscopically evaluated and group based 
on morphological criteria, in the next quality codes presented in table 2. 
 
Table 2 
Embryos classification based on morphological criteria 
Embryos 
N 
Very good 
Code 1 
Good 
Code 2 
Satisfying 
Code 3 
Poor/Very poor 
Code 4 
n % n %  n  %  n  % 
37 2  5.40
a 6  16.21
ac 11  29.72
Aa 18 48.64
 A 
Test χ
2, A-a p ≤ 0,001; A-c p ≤0,05; a-a p >0,05 
 
Based on morphological criteria 5.40% embryos were classified as code 1,, 
16.21% were assessed as quality code 2, 29.72% were assessed as quality code 3 
and most of the embryos (48.64%) were assessed as quality code 4.    3
After morphological evaluation the embryos were tested by esterasic activity 
detection using FDA staining test. The results obtained are presented in table 3. 
 
Table 3 
Embryos viability assessment using FDA staining test 
Embryos 
Viability 
Viable Nonviable 
N N % N % 
37 24  64.8
A 13 35.2
b 
Test χ
2, A-b p ≤0,01  
 
Following FDA staining 64.8% of the embryos were evaluated as viable 
(showed green fluorescence while were exposed to the fluorescence source), and 
35.2% embryos were evaluated as nonviable (low number of blastomers showing 
green fluorescence). Within the proportion of viable and nonviable embryos were 
observed distinct significant differences (p ≤0.01). 
To establish a correlation between the two methods used for embryo quality 
and viability assessment (morphological criteria versus FDA staining) we applied 
the Pearson coefficient. The calculated value of the Pearson coefficient was r = 1, 
which indicates a perfect positive correlation between the two variables compared 
and indicates a strong correlation between the two methods.  
In the pictures bellow are presented embryos evaluated by FDA staining test  
(Figure 1, 2, 3, 4). 
 
Figure 1. Fragmented embryos showing 
green fluorescence within the blastomers 
which presented esterasic activity  
(original) 
Figure 2. Viable embryos evaluated by 
FDA staining teste 
(original) 
Fragmented embryos exposed to FDA staining showed green fluorescence 
within the blastomers which presented esterasic activity. After exposure to the 
fluorescence source the emission rates of fluorescence varied direct proportional 
with the intensity of the enzymatic activity within the blastomers. According to the 
specialty references the emission rate of the fluorescence are typically 10
8 s
-1 , so 
that the fluorescence lifetime is near 10 nanoseconds. Many fluorophores displays 
subnanoseconds lifetime (Lakowicz, 2006). 
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Figure 3. Blastocyst and hatched blastocyst 
evaluated as viable by Fluorescein diacetat 
staining test (original) 
Figure 4. Viable blastocyst evaluated by 
Fluorescein diacetat staining test (original) 
 
 
The nonviable embryos without enzymatic activity inside the cells lost their 
capacity to bind and transform the Fluorescein dictate to fluorescein and showed no 
fluorescence while were exposed to the fluorescence sours of the microscope. 
 
Conclusions 
1.  Based on morphological criteria 5.40% embryos were classified as code 1, 
16.21% were assessed as quality code 2, 29.72% were assessed as quality 
code 3 and most of the embryos (48.64%) were assessed as quality code 4.  
2.  Following FDA staining 64.8% of the embryos were evaluated as viable 
(showed green fluorescence while were exposed to the fluorescence 
source), and 35.2% embryos were evaluated as nonviable (low number of 
blastomers showing green fluorescence). The differences were distinct 
significant (p ≤0.01). 
3.  The calculated value of the Pearson coefficient was r = 1 which indicates a 
strong positive correlation between the two variables compared and 
indicates a strong correlation between the two methods (morphological 
criteria and FDA staining test). 
4.  Esterasic activity detection by fluorescence staining is an easy, fast and 
objective method for embryo viability assessment. 
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